Treating Cancer From the Outside In: The Preclinical & Early Clinical Development of PF-08052667 for Non Muscle Invasive Bladder Cancer

1:03 pm - Wednesday 10th March 2027

  • Preclinical optimisation of ADC for local bladder treatment
  • Strong preclinical efficacy with limited systemic exposure
  • Clinical development of PF-08052667

Speakers:

Senior Director, ADC Pharmcology
Pfizer